APA (7th ed.) Citation

P, G., M, H., MF, S., N, V., A, S., F, A., . . . D, R. (2020). Elvitegravir-Cobicistat-Emtricitabine-Tenofovir Alafenamide Single-tablet Regimen for Human Immunodeficiency Virus Postexposure Prophylaxis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 70(5), 943. https://doi.org/10.1093/cid/ciz577

Chicago Style (17th ed.) Citation

P, Gantner, et al. "Elvitegravir-Cobicistat-Emtricitabine-Tenofovir Alafenamide Single-tablet Regimen for Human Immunodeficiency Virus Postexposure Prophylaxis." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 70, no. 5 (2020): 943. https://doi.org/10.1093/cid/ciz577.

MLA (9th ed.) Citation

P, Gantner, et al. "Elvitegravir-Cobicistat-Emtricitabine-Tenofovir Alafenamide Single-tablet Regimen for Human Immunodeficiency Virus Postexposure Prophylaxis." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 70, no. 5, 2020, p. 943, https://doi.org/10.1093/cid/ciz577.